Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
:PHN
PHN Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PHN Stock 12 Month Forecast
Average Price Target
€81.00
▲(65.47% Upside)
| Highest Price Target€85.00 | Average Price Target€81.00 | Lowest Price Target€74.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TP ICAP MIDCAP
€74
Buy
51.17%
Upside
Reiterated
11/21/25
Intermonte
€84
Buy
71.60%
Upside
Reiterated
11/11/25
PharmaNutra SpA: Strategic Growth and Strong Financials Justify Buy RatingWe leave FY25 revenue unchanged, implying +11% growth in 4Q, while we raise our full-year EBITDA margin estimate from 25.1% to 25.8% (22% margin in 4Q), resulting in a €1mn lift to EBITDA (+3%). However, this improvement is largely offset by higher taxes, leading to a neutral impact on EPS.
Berenberg Bank
€85
Buy
73.65%
Upside
Reiterated
11/11/25
Stifel Nicolaus
€88
Buy
79.78%
Upside
Reiterated
03/26/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TP ICAP MIDCAP
€74
Buy
51.17%
Upside
Reiterated
11/21/25
Intermonte
€84
Buy
71.60%
Upside
Reiterated
11/11/25
PharmaNutra SpA: Strategic Growth and Strong Financials Justify Buy RatingWe leave FY25 revenue unchanged, implying +11% growth in 4Q, while we raise our full-year EBITDA margin estimate from 25.1% to 25.8% (22% margin in 4Q), resulting in a €1mn lift to EBITDA (+3%). However, this improvement is largely offset by higher taxes, leading to a neutral impact on EPS.
Berenberg Bank
€85
Buy
73.65%
Upside
Reiterated
11/11/25
Stifel Nicolaus
€88
Buy
79.78%
Upside
Reiterated
03/26/25
Best Analysts Covering PharmaNutra SpA
1 Month
xxx
Success Rate
4/9 ratings generated profit
Average Return
+1.42%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of +1.42% per trade.
3 Months
xxx
Success Rate
7/12 ratings generated profit
Average Return
+1.59%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +1.59% per trade.
1 Year
Success Rate
7/9 ratings generated profit
Average Return
+3.41%
reiterated a buy rating 29 days ago
Copying Corentin Marty's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +3.41% per trade.
2 Years
xxx
Success Rate
7/9 ratings generated profit
Average Return
+5.59%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +5.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PHN Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
2
4
6
4
Buy
4
4
5
4
4
Hold
2
1
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
7
9
11
9
Each month's total comprises the sum of three months' worth of ratings.
PHN Financial Forecast
PHN Stock Forecast FAQ
What is IT:PHN’s average 12-month price target, according to analysts?
Based on analyst ratings, PharmaNutra SpA’s 12-month average price target is 81.00.
What is IT:PHN’s upside potential, based on the analysts’ average price target?
PharmaNutra SpA has 65.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PharmaNutra SpA a Buy, Sell or Hold?
PharmaNutra SpA has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is PharmaNutra SpA’s share price target?
The average share price target for PharmaNutra SpA is 81.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €85.00 ,and the lowest forecast is €74.00. The average share price target represents 65.47% Increase from the current price of €48.95.
The highest analyst share price target is €85.00 ,and the lowest forecast is €74.00. The average share price target represents 65.47% Increase from the current price of €48.95.
What do analysts say about PharmaNutra SpA?
PharmaNutra SpA’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of PharmaNutra SpA?
To buy shares of IT:PHN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.